Epidemiology of Multiple Sclerosis: A Critical Overview

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Volumn 20, Issue 1, 1993, Pages 17-29

  Sadovnick, A D ^a,b   Ebers, G C ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; CONTROLLED STUDY; EPIDEMIOLOGY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW;

FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0027398162     PISSN: 03171671     EISSN: 20570155     Source Type: Journal    
DOI: 10.1017/S0317167100047351     Document Type: Article

References (162)

1. Fox JP, Hall CE, Elveback LR. Epidemiology: Man and Disease. Toronto: The Macmillan Co, 1970: 185.
2. Charcot JM. Lectures on the Diseases of the Nervous System. Vol 1. (Translated by Sigerson G.). London: The New Sydenham Society, 1877: 157–222.
3. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. In: Poser CM, Paty DW, Scheinberg L, Ebers GC, eds. The Diagnosis of Multiple Sclerosis. New York: Thieme-Stratton Inc, 1984: 225–233.
4. Poskanzer DC, Schapira K, Miller H. Multiple sclerosis and poliomyelitis. The Lancet 1963; ii: 917–921.
5. Dupont B, Lisak RP, Jersild C, et al. HLA antigens in black American patients with multiple sclerosis. Transpl Proc 1976; 91 (Suppl I): 181–185.
6. Hader WJ, Feasby TE, Noseworthy JH, et al. Multiple sclerosis in Canadian Native People. Neurology 1985; 35 (Suppl 1): 300.
7. McCall MG, Brereton T. Le G. Dawson A, et al. Frequency of multiple sclerosis in three Australian centres, Perth, Newcastle and Hobart. J Neurol Neurosurg Psychiatry 1968; 31: 1–9.
8. Antonovsky A, Leibowitz U, Medalie JM, et al. Reappraisal of possible aetological factors in multiple sclerosis. Am J Public Health 1968; 58: 836–848.
9. Dean G. Annual incidence, prevalence and mortality of MS in white South African-born and in white immigrants to South Africa. Br Med J 1967; 2: 724–730.
10. Alter M, Hapern L, Kurland LT, et al. Multiple sclerosis in Israel: prevalence among migrants and native inhabitants. Arch Neurol 1962; 7: 253–263.
11. Alter M, Leibowitz U, Speer J. Risk of multiple sclerosis related to age of immigration to Israel. Arch Neurol 1966; 15: 234–237.
12. Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Part One. Acta Neurol Scand 1975; 51: 110–136.
13. Bauer HJ. Multiple sclerosis in Europe. Symposium Report. J Neurol 1987; 234: 195–206.
14. Vassallo L, Elian M, Dean G. Multiple sclerosis in southern Europe. II. Prevalence in Malta in 1978. J Epidemiol Comm Health 1979; 33: 111–113.
15. Dean G, Grimaldi G, Kelly R, et al. Multiple sclerosis in southern Europe. I. Prevalence in Sicily in 1975. J Epidemiol Comm Health 1979; 33: 107–110.
16. Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Part Two. Acta Neurol Scand 1975; 51: 137–157.
17. Davenport CB. Multiple sclerosis from the standpoint of geographic distribution and race. Arch Neurol 1922; 8: 51–58.
18. Bing R, Reese H. Die Multiple Sklerose in der Nordestschweiz. Schweiz Med Wochenschr 1926; 56: 30–34.
19. Allison RS. Disseminated sclerosis in North Wales: an inquiry into its incidence, frequency, distribution and other etiological factors. Brain 1931; 53: 301–430.
20. Alter M, Leewenson R, Harshe M. The geographic distribution of multiple sclerosis: an examination of mathematical models. J Chron Dis 1973; 26: 755–767.
21. Kurtzke JF. Geography in multiple sclerosis. J Neurol 1977; 215: 1–26.
22. Hammond SR, de Wytt C, Maxwell LC, et al. The epidemiology of multiple sclerosis in Queensland, Australia. J Neurol Sei 1987; 80: 185–204.
23. Hammond SR, McLeod JG, Millingen KS, et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 1988; 111: 1–25.
24. Leiter E.H., Serreze D.V., Prochazka M. The genetics and epidemiology of diabetes in NOD mice. Immunol Today 1990; 11: 147–149.
25. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility: a critical review. J Neuroimmunol, in press, 1993.
26. Sweeney VP, Sadovnick AD, Brandejs V. Prevalence of multiple sclerosis in British Columbia. Can J Neurol Sci 1986; 13: 47–51.
27. Westlund KB, Kurland LT. Studies on multiple sclerosis in Winnipeg, Manitoba and New Orleans, Louisiana. I. Prevalence. Comparison between the patient groups in Winnipeg and New Orleans. Am J Hyg 1953; 57: 380–396.
28. Stazio A, Kurland LT, Bell GL, et al. Multiple sclerosis in Winnipeg, Manitoba. Methodological consideration of epidemiologic survey: ten-year follow-up of a community-wide study and population re-survey. J Chron Dis 1964; 17: 415–438.
29. Hader WJ, Elliot M, Ebers GC. Epidemiology of multiple sclerosis in London and Middlesex County. Ontario. Canada. Neurology 1988; 38:617–621.
30. Alter M, Allison RS, Talbert OR, et al. The geographic distribution of multiple sclerosis. A comparison of prevalence in Charleston County, South Carolina and Halifax County, Nova Scotia. II. Prevalence in Halifax County, Nova Scotia. NS Med Bull 1960; 39: 203–210.
31. White DN, Wheelan L. Disseminated sclerosis. A survey of patients in the Kingston, Ontario, area. Neurol 1959; 9: 256–272.
32. Hader WJ. Prevalence of multiple sclerosis in Saskatoon. Can Med Assoc J 1982; 127: 295–297.
33. Bennett L, Hamilton R, Neutel CI, et al. Survey of persons with multiple sclerosis in Ottawa, 1974-1975. Can J Public Health 1977; 68: 141–147.
34. Pryse-Phillips WEM. The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960-1984. Ann Neurol 1986; 20: 323–328.
35. Cendrowski W, Wender M, Dominik W. et al. Epidemiological study of multiple sclerosis in Western Poland. Eur Neurol 1968; 2: 90–103.
36. Wender M, Pruchnik-Grabowska D, Hertmanowska H, et al. Epidemiology of multiple sclerosis in Western Poland. Acta Neurol Scand 1985; 72: 210–217.
37. Percy AK, Nobrega FT, Okazaki H, et al. Multiple sclerosis in Rochester, Minn: a 60-year appraisal. Arch Neurol 1971; 25: 105–111.
38. Kranz JMS, Kurland LT, Schuman LM, et al. Multiple sclerosis in Olmsted and Mower Counties, Minnesota. Neuroepidemiology 1983; 2: 206–218.
39. Wynn DR, Kurland LT, O'Fallon WM, et al. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990; 40: 780–786.
40. Wynn DR, Rodriguez M, O'Fallon WM, et al. Update on the epidemiology of multiple sclerosis. Mayo Clinic Proc 1989; 64: 808–817.
41. Larsen JP, Aarli JA, Riise T. Western Norway, a high risk area for multiple sclerosis. A prevalence/incidence study in the county of Hordaland. Neurology 1984; 34: 1202–1207.
42. Midgard R, Riise T, Nyland H. Epidemiologic trends in multiple sclerosis in More and Romsdal, Norway. A prevalence/incidence study in a stable population. Neurology 1991; 41: 887–892.
43. Granieri E, Rosati G. Italy: A medium- or high-risk area for multiple sclerosis? An epidemiologic study in Barbagia, Sardinia, southern Italy. Neurology 1982; 32: 466–472.
44. Granieri E, Rosati G, Tola R, et al. The frequency of multiple sclerosis in Mediterranean Europe. An incidence and prevalence study in Barbagia, Sardinia, insular Italy. Acta Neurol Scand 1983; 68: 84–89.
45. Presthus J. Report on the multiple sclerosis investigations in West-Norway. Acta Psychiat Neurol Scand 1960; 35 (Suppl 147): 88–92.
46. Garcia JR, Rodriguez S, Henriquez MS, et al. Prevalence of multiple sclerosis in Lanzarote (Canary Islands). Neurol 1989; 39: 265–267.
47. Gilbert JJ, Sadler M. Unsuspected multiple sclerosis. Arch Neurology 1983; 40: 533–536.
48. Kurtzke JF, Bui QH. Multiple sclerosis in a migrant population. II. Half-orientals immigrating in childhood. Ann Neurol 1980; 8: 256–260.
49. Detels R, Visscher BR, Haile RW, et al. Multiple sclerosis and age at migration. Am J Epidemiol 1978; 108: 386–393.
50. Elian M, Nightingale S, Dean G. Multiple sclerosis among the United Kingdom born children of immigrants from the Indian Subcontinent, Africa and the West Indies. J Neurol Neurosurg Psychiatry 1990; 53: 906–911.
51. Biton V, Abramsky O. New study fails to support environmental factors in etiology of multiple sclerosis. Neurology 1986; 36 (Suppl 1): 184.
52. McKusick VA. Mendelian Inheritance in Man. 5th Edition. Baltimore: The John Hopkins University Press, 1978, pp IX.
53. Sheremata WA, Poskanzer DC, Withum DG, et al. Unusual occurrence on a tropical island of multiple sclerosis. The Lancet 1985; ii: 618.
54. Irvine DG, Schiefer HB, Hader WJ. Geotoxicology of multiple sclerosis: the Henribourg, Saskatchewan, cluster focus. II. The soil. Sci Total Environment 1988; 77: 175–188.
55. Stein EC, Schiffer RB, Hall J, et al. Multiple sclerosis and the workplace: report of an industry-based cluster. Neurology 1987; 37: 1672–1677.
56. Murray TJ. An unusual occurrence of multiple sclerosis in a small rural community. Can J Neurol Sci 1976; 3: 163–166.
57. Kinnunen E. Multiple sclerosis in Finland: evidence of increasing frequency and uneven geographic distribution. Neurology 1984; 34: 457–461.
58. Larsen JP, Riise T, Nyland H, et al. Clustering of multiple sclerosis in the county of Hordaland, Western Norway. Acta Neurol Scand 1985; 71: 390–395.
59. Hoffman RE, Zack MM, Davis LE, et al. Increased incidence and prevalence of multiple sclerosis in Los Alamos County, New Mexico. Neurology 1981; 31: 1489–1492.
60. Eastman R, Sheridan J, Poskanzer DC. Multiple sclerosis clustering in a small Massachusetts community, with possible common exposure 23 years before onset. N Engl J Med 1973; 289: 793–794.
61. Poskanzer DC, Prenney LB, Sheridan JL, et al. Multiple sclerosis in the Orkney and Shetland Islands. 1. Epidemiology, clinical factors and methodology. J Epidemiol Comm Health 1980; 34: 229–239.
62. Poskanzer DC, Walker AM, Prenney LB, et al. The etiology of multiple sclerosis: temporal-spatial clustering indicating two environmental exposures before onset. Neurology 1981; 31: 708–713.
63. Conomy JP, Namey M, Rudick R, et al. Multiple sclerosis in Galion, Ohio: a cluster in time or a cluster in space? Neurology 1989; 39 (Suppl I): 284.
64. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological features. Ann Neurol 1979; 5: 6–21.
65. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of multiple sclerosis. Neurology 1986; 36: 307–328.
66. Acheson ED. The pattern of the disease. In: Matthews WB, Acheson ED, Batchelor JR, Weller RO, eds. McAlpine's Multiple Sclerosis. New York: Churchill Livingstone, 1985: 22–25.
67. Poser CM, Hibberd Pl Benedikz, et al. Analysis of the “epidemic” of multiple sclerosis in the Faroe Islands. 1. Clinical and epidemiological aspects. Neuroepidemiology 1988; 7: 168–180.
68. Poser CM, Hibberd PL. Analysis of the “epidemic” of multiple sclerosis in the Faroe Islands. I. Biostatistical aspects. Neuroepidemiology 1988; 7: 181–189.
69. Kurtzke JF, Hyllested K. Validity of the epidemics of multiple sclerosis in the Faroe Islands. Neuroepidemiology 1988; 7: 190–227.
70. Kurtzke JF, Gudmundsson KR, Bergmann S. Multiple sclerosis in Iceland: I. Evidence of a postwar epidemic. Neurology 1982; 32: 143–150.
71. Acheson ED. Epidemiology of multiple sclerosis. Br Med Bull 1977; 33: 9–14.
72. Ebers GC. Multiple sclerosis and other demyelinating diseases. In: Asbury A, McKhann G, McDonald I, eds. Diseases of the Nervous System. Pennsylvania: WB Saunders Company, 1986: 1268–1281.
73. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically-based study. I. Clinical course and disability. Brain 1989; 112: 133–146.
74. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically-based study. 2. The predictive value of the early clinical course. Brain 1989; 112: 1419–1428.
75. Duquette P, Murray TJ., Pleines J, et al. Multiple sclerosis in child-hood: clinical profile in 125 patients. J Pediat 1987; 111: 359–363.
76. Sadovnick AD, Ebers GC, Eisen K, et al. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991; 41: 1193–1196.
77. Weitkamp LR. Multiple sclerosis susceptibility: interaction between sex and HLA. Arch Neurol 1983; 40: 399–401.
78. Sadovnick AD, Bulman DE, Ebers GC. Influence of gender on the susceptibility to multiple sclerosis in siblings. Arch Neurol 1991; 48: 586–588.
79. Grufferman S., Cole PG., Lukes RJ. Hodgkin's disease in siblings. N Engl J Med 1977; 296: 248–250.
80. Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Med 1965: 122: 552–568.
81. Matthews WB. Course and prognosis. In: Matthews WB, Acheson ED, Batchelor JR, Weller RO, eds. McAlpine's Multiple Sclerosis. New York: Churchill Livingstone, 1985: 49–52.
82. Noseworthy J, Paly DW, Wonnacott T, et al. Multiple sclerosis after age 50. Neurology 1983; 33: 1537–1544.
83. Bulman DE., Sadovnick AD, Ebers GC. Age of onset in siblings concordant for multiple sclerosis. Brain 1991; 114: 937–950.
84. Sadovnick AD, Hashimoto LL, Hashimoto SA. Heterogeneity in multiple sclerosis’, comparison of clinical manifestations in relatives. Can J Neurol Sci 1990, 17: 387–439.
85. Swank RL. Multiple sclerosis, correlation of its incidence with dietary fat. Am J Med Sci 1951; 220: 421–430.
86. Butler EJ. Chronic neurological disease as a possible form of lead poisoning. J Neurol Neurosurg Psychiatry 1952; 15: 119–128.
87. Matthews WB. Some aspects of the natural history. In: Matthews WB, Acheson ED, Batchelor JR, Weller RO. eds. McAlpine's Multiple Sclerosis. New York: Churchill Livingstone, 1985: 73–95.
88. Cook SD, Dowling PC. A possible association between housepets and multiple sclerosis. The Lancet 1977; i: 980–982.
89. Bunnell DH, Visscher BR, Detels R. Multiple sclerosis and house clogs: a case control study. Neurology 1979; 29: 1027–1029.
90. Poskanzer DC, Prenney LB, Sheridan JL. Housepets and multiple sclerosis. Lancet 1977; i: 1204.
91. Read D., Nassim D, Smith P, et al. Multiple sclerosis and dog ownership: a case-control investigation. J Neurol Sci 1982; 55: 359–367.
92. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985; 1313–1315.
93. Gay D, Dick G, Upton G. Multiple sclerosis associated with sinusitis: case-controlled study in general practice. Lancet 1986; i: 815–819.
94. Sibley WA, Foley JM. Infection and immunization in mutliple sclerosis. Ann NY Acad Sci 1965; 122: 457–468.
95. D'Hooghe MB, Ebers GC. A population-based study of seasonal onset of multiple sclerosis in London, Ontario. Abstract. Neurology 1989; 39 (Suppl I): 284.
96. Bamford CR, Sibley WA, Thies C, et al. Trauma as an etiologic and aggravating factor in multiple sclerosis. Neurology 1981; 31: 1229–1234.
97. McAlpine D, Compston ND. Some aspects of the natural history of disseminated sclerosis. J of Med 1952; 21: 135–167.
98. Millar JHD, Allison RS, Cheesman EA. et al. Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain 1959; 82: 417–426.
99. Koopmans RA, Li DKB, Oger J.J.-F. et al. The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology 1989a; 39: 959–963.
100. Willoughby EW., Grochowski E, Li DKB. et al. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 1989; 25: 43–49.
101. Isaac C, Li DKB, Genton M, et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 1988; 38: 1511–1515.
102. Birk K., Ford C, Smeltzer S, et al. The clinical course of multiple sclerosis during pregnancy and the Puerperium. Arch Neurol 1990; 47: 738–742.
103. Sadovnick AD, Paty DW, Hashimoto SA, et al. Multiple sclerosis and pregnancy: a prospective study. Abstract. Neurol 1990; 40 (Suppl 1): 141.
104. Barnett GO, Justice NS, Somand ME. et al. COSTAR – a computer-based medical information system for ambulatory care. Proc IEEE 1979; 67: 1226–1237.
105. Holmes FF, Stubbs DW, Larsen WE. Systemic lupus erythematosus and multiple sclerosis in identical twins. Arch Intern Med 1967; 119: 302.
106. Margolis LN, Graves RW. The occurrence of myasthenia gravis in a patient with multiple sclerosis. NC Med J 1945; 24: 243–244.
107. Aita JF, Snyder DH, Reichl W. Myasthenia gravis and multiple sclerosis: an usual combination of diseases. Neurology 1974; 24: 72–75.
108. Shakir RA, Hussuen JM, Trontelj JV. Myasthenia gravis and multiple sclerosis. J Neuroimmunol 1983; 4: 161–165.
109. Matthews WB. The neurological complications of ankylosing spondylitis. J Neurol Sei 1968; 5: 561–573.
110. Thomas DJ, Kendall MJ, Whitfield AGW. Nervous system involvement in ankylosing spondylitis. Br Med J 1974; 1: 148–150.
111. Sadovnick AD, Paty DW, Yannakoulias G. Concurrence of multiple sclerosis and inflammatory bowel disease. N Engl J Med 1989: 321: 762–763.
112. Trostle DC, Helfrich D, Medsger TA Jr. Systemic sclerosis (scleroderma) and multiple sclerosis. Arthritis Rheum 1986; 29: 124–127.
113. Bias WB, Reveille JD, Beaty TH, et al. Evidence that autoimmunity in man is a Mendelian dominant trait. Am J Hum Genet 1986; 39: 584–602.
114. Wynn DR, Codd MB, Kurland LT, et al. Multiple sclerosis: a population-based investigation of the association with possible autoimmune diseases and diabetes mellitus. Abstract. Neurology 1987; 37 (Suppl 1): 272.
115. Linos A, Worthington JW, O'Fallon WM, et al. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence and mortality. Am J Epidemiol 1980; 111: 87–98.
116. Furszyfer J, Kurland LT, McConahey WM, et al. Epidemiologic aspects of Hashimoto's thyroiditis and Graves disease in Rochester, Minnesota (1935-1967), with special reference to temporal trends. Metabolism 1972; 3: 197–204.
117. Warren S, Warren KG. Multiple sclerosis and associated diseases: a relationship to diabetes mellitus. Can J Neurol Sei 1981: 8: 35–39.
118. Wynn DR, Codd MB, Kurland LT, et al. Multiple sclerosis: a population-based investigation of the association with neoplastic disorders. Abstract. Neurology 1987; 37 (Suppl I): 151.
119. Sibley WA, Bamford CR, Laguna JF. Anamnestic studies in multiple sclerosis: a relationship between familial multiple sclerosis and neoplasia. Neurology 1978; 28: 125–128.
120. Zimmerman HM, Netsky MG. The pathology of multiple sclerosis. Res Publ Assoc Res Nerv Ment Dis 1950; 28: 271–312.
121. Castaigne P., Escourelle R, Brunet P, et al. Reticulosarcome cerebral primitif associe a des lesions de sclerose en plaques. Res Neurol 1974; 130: 181–188.
122. Currie S., Urich H. Concurrence of multiple sclerosis and glioma. J Neurol Neurosurg Psychiatry 1974; 37: 598–605.
123. Reagan TJ, Frieman IS. Multiple cerebral gliomas in multiple sclerosis. J Neurol Neurosurg Psychiatry 1973; 36: 523–528.
124. Lynch PG. Multiple sclerosis and malignant glioma. Br Med J 1974; 3: 577.
125. Poskanzer DC, Prenney LB, Sheridan JL, Kondy JY. Multiple sclerosis in the Orkney and Shetland Islands. I. Epidemiology, clinical factors and methodology. J Epidemiol and Comm Health 1980; 34: 229-239.
126. Allen IV, Millar JHD, Hutchinson MJ. General disease in 120 necropsy-proven cases of multiple sclerosis. Neuropathol App Neurobiol 1978; 4: 279–284.
127. Warren S, Warren KG. Prevalence of multiple sclerosis in Barrhead County, Alberta, Canada. Can J Neurol Sei 1992: 19: 72–75.
128. Klein GM, Seland TP, Barclay L, Orman AV. An epidemiological study of multiple sclerosis in the Crowsnest Pass and Cardston regions of southern Alberta. Can J Neurol Sci 1990; 17: 241.
129. Gallou M, Madigand M, Masse L, et al. Epidemiologie de la sclerose en plaques en Bretagne. Presse Med 1983; 12: 995–999.
130. Lauer K, Firnhaber W, Reining R, et al. Epidemiological investigations into multiple sclerosis in Southern Hesse. I. Methodological problems and basic epidemiological characteristics. Acta Neurol Scand 1984; 70: 257–265.
131. Milonas I, Tsounis S, Logothetis I. Epidemiology of multiple sclerosis in northern Greece. Acta Neurol Scand 1990; 81: 43–47.
132. Yu YL, Woo E, Hawkins BR, et al. Multiple sclerosis amongst Chinese in Hong Kong. Brain 1989; 112: 1445–1467.
133. Palffy G. MS in Hungary, including the gipsie population. In: Kuroiwa Y, Kurland LT, eds. Multiple Sclerosis. East and West. Kyushu: Kyushu University Press, 1982: 149–157.
134. Wadia NH, Bhatia K. Multiple sclerosis is prevalent in the Zoroastrians (Parsis) of India. Ann Neurol 1990; 28: 177–179.
135. Leibowitz U, Kahana E, Alter M. Multiple sclerosis in immigrant and native populations of Israel. The Lancet 1970; 1: 1323–1325.
136. Sironi L, Mamoli A, D'Alessandro G, et al. Frequency of multiple sclerosis in Valle d'Aosta, 1971-1985. Neuroepidemiology 1991; 10: 66–69.
137. Kuroiwa Y, Shibasaki H, Ikeda M. Prevalence of multiple sclerosis and its north-south gradient in Japan. Neuroepidemiology 1983: 2: 62–69.
138. Kim SW, Kim SY. Multiple sclerosis in Busan, Korea. Clinical features and prevalence. In: Kuroiwa Y, Kurland LT, eds. Multiple Sclerosis. East and West. Kyushu: Kyushu University Press, 1982: 57–69.
139. Park CS. Multiple sclerosis in Korea. Neurology 1966; 16: 919–926.
140. Al-Din ASN. Multiple sclerosis in Kuwait: clinical and epidemiological study. J Neurol Neurosurg Psychiatry 1986; 49: 928–931.
141. Radhakrishnan K, Ashok PP, Sridharan R, et al. Prevalence and pattern of multiple sclerosis in Benghazi, North-Eastern Libya. J Neurol Sci 1985; 70: 39–46.
142. Tan C-T. Multiple sclerosis in Malaysia. Arch Neurol 1988; 45: 624–627.
143. Alter M, Olivares L. Multiple sclerosis in Mexico. Arch Neurol 1970; 23: 451–459.
144. Skegg DCG, Corwin PA, Craven RS. et al. Occurrence of multiple sclerosis in the north and south of New Zealand. J Neurol Neurosurg Psychiatry 1987: 50: 134–139.
145. Yaquib BA, Daif AK. Multiple sclerosis in Saudi Arabia. Neurology 1988; 38: 621–623.
146. 13).
147. Bartschi-Rochaix W. MS in Switzerland Canton Wallis. In: Bauer HJ, Poser S, Ritter G, eds. Progress in Multiple Sclerosis Research. New York: Springer, 1980: 535–538.
148. Hung T-P. Multiple sclerosis in Taiwan: a reappraisal. In: Kuroiwa Y, Kurland LT, eds. Multiple Sclerosis. East and West. Kyushu: Kyushu University Press. 1982: 83–96.
149. Ben Hamida M. La sclerose en plaques en Tunisie: etude clinique de 100 observations. Rev Neurol (Paris) 1977: 33: 109–117.
150. Williams ES, McKeran RO. Prevalence of multiple sclerosis in a south London borough. Br Med J 1986; 293: 237–239.
151. Swingler RJ, Compston DAS. The prevalence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 1988: 51: 1520–1524.
152. Phadke JG, Downie AW. Epidemiology of multiple sclerosis in the north-east (Grampian Region) of Scotland – an update. J Epidemiol Comm Health 1987; 41: 5–13.
153. Cook SD, MacDonald J, Tapp W. et al. Multiple sclerosis in the Shetland Islands: an update. Acta Neurol Scand 1988; 77: 148–151.
154. Cook SD, Cromarty JI, Tapp W. et al. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology 1985; 35: 545–551.
155. Dean G, Goodall J, Downie A. The prevalence of multiple sclerosis in the Outer Hebrides compared with north-east Scotland and the Orkney and Shetland Islands. J Epidemiol Comm Health 1981: 35: 110–113.
156. Alter M, Okihiro M, Rowley W, et al. Multiple sclerosis among orientals and Caucasians in Hawaii. Neurology 1971; 21: 122–130.
157. Enstrom JE, Operskalski EA. Multiple sclerosis among Spanish-surnamed Californians. Neurology 1978; 28: 434–438.
158. Visscher BR, Detels R, Coulson AH et al. Latitude, migration and the prevalence of multiple sclerosis. Am J Epidemiol 1977; 106: 470–475.
159. Sepcic J, Antonelli L, Materljan E, et al. Multiple sclerosis cluster in Gorski Kotar, Croatia, Yugoslavia. In: Battaglia MA, ed. Multiple Sclerosis Research. Amsterdam: Elsevier Science Pub, 1989: 165–169.
160. Rosati G, Aiello I, Pirastru MI. et al. Sardinia: a high-risk area for multiple sclerosis: a prevalence and incidence study in the district of Alghero. Ann Neurol 1987; 21: 190–194.
161. Salerni E, D'Aurizio CD, Andrea FD. et al. A prevalence study of multiple sclerosis in L*Aquila, central Italy. Clin Neurol Neurosurg 1988; 90: 112–116.
162. Granieri E, Tola R, Paolino E, et al. The frequency of multiple sclerosis in Italy: a descriptive study in Ferrara. Ann Neurol 1985; 17: 80–84.